| AB FCP II-EMERGING MARKETS VALUE PORTFOLIO I EUR | RVI EMERGENTES VALOR | 91,820000 | 17/09/2026 | 32,52% | 76,58% | **** |
| PICTET - BIOTECH R USD | RVI BIOTECNOLOGÍA | 1.127,454055 | 17/09/2026 | 17,62% | 76,58% | **** |
| UBS MSCI EM SOCIALLY RESPONSIBLE UCITS ETF USD DIS | RVI EMERGENTES | 20,320791 | 17/09/2026 | 32,17% | 76,57% | **** |
| JANUS HENDERSON HF - JAPANESE SMALLER COMPANIES H2 USD HEDGED | RVI JAPÓN SMALL/MID CAP | 132,209738 | 17/09/2026 | 27,89% | 76,53% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 518,310000 | 17/09/2026 | 22,19% | 76,51% | **** |
| GOLDMAN SACHS GLOBAL FUTURE ECONOMIC SECURITY EQUITY PORTFOLIO R GBP DIS | RVI GLOBAL | 21,088198 | 17/09/2026 | 24,33% | 76,51% | ***** |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO I (CLOSE) EUR CAP | RVI EMERGENTES | 18,690000 | 17/09/2026 | 29,61% | 76,49% | **** |
| SCHRODER ISF EMERGING MARKETS B ACC USD | RVI EMERGENTES | 21,631391 | 17/09/2026 | 26,90% | 76,48% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | RVI BIOTECNOLOGÍA | 394,225242 | 17/09/2026 | 22,31% | 76,47% | **** |
| SCHRODER ISF FRONTIER MARKETS EQUITY I ACC USD | RVI EMERGENTES | 434,812473 | 17/09/2026 | 17,91% | 76,47% | **** |
